Skip to main content
. 2017 Nov 3;18:104–108. doi: 10.1016/j.ijcha.2017.10.002

Table 1.

Patient characteristics.

Patient number Age (years) Wt (kg) Gender HIV HAART ART therapy CD4 (cells/μl) Creatinine (μmol/l) Globulin (g/l) Steroid allocation Pericardial protein (g/l) ADA (units/l) TB microscopy
1 28 53 male Positive No N/A 115 76 46 Placebo 58 Hemolyzed Positive
2 29 40 female Positive No N/A 50 20 45 Placebo 54 83 Positive
3 24 66 female Positive No N/A 42 43 56 Prednisolone 68 57 Positive
4 56 82 male Negative N/A N/A 485 121 30 Placebo 62 133 Positive
5 31 72 male Negative N/A N/A 319 82 36 Prednisolone 55 119 Positive
6 51 53 female Positive Yes Tdf/FTC/EFV 159 80 56 Placebo 50 53 Negative
7 24 45 female Positive No N/A 321 257 56 Placebo 67 92 Positive
8 27 66 female Positive No N/A 135 45 55 Prednisolone 70 26 Positive
9 44 52 female Positive No N/A 139 65 56 Prednisolone 66 51 Negative
10 59 66 male Negative N/A N/A 874 97 38 Prednisolone 62 33 Negative
11 45 70 male Negative N/A N/A 721 109 47 Placebo 76 32 Negative
12 33 47 male Positive No N/A 116 71 49 Placebo 61 130 Positive
13 25 73 male Positive No N/A a 73 a Placebo 55 38 Positive
14 27 a female Positive Yes Tdf/FTC/EFV 255 41 74 Placebo 76 68 Negative
a

Data not available.